Cancer and Autoimmune Diseases to Propel Monoclonal Antibody Therapeutics Market at Solid 12.6% CAGR
Monoclonal antibodies are a type of biological therapy used in the treatment serious conditions such as cancer, rheumatoid arthritis, Crohn's diseases, psoriasis, osteoporosis, systemic lupus erythematous, and others. Monoclonal antibody are target specific in action by not affect the other cells of the body thus restores the immune system.
View full press release